Logo (Accord Logo)
Filkri Injection, Solution
Product Images NDC 69448-009
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Filkri (NDC 69448-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Accord Biopharma Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Filkri 01)
An instructional diagram showing a prefilled syringe labeled with parts before and after use, including plunger rod, needle guard activation clip, finger grip, label and expiration date, safety guard with spring, syringe barrel, medicine window with dose markings, and needle cap, illustrating the safety features and proper use of the syringe.*
Image (Filkri 02)
An instructional illustration showing hands holding a pre-filled syringe inside a plastic tray. The syringe includes a graduated scale and a plunger, indicating it is ready for injection use. This image likely demonstrates proper handling or preparation of the injection device.*
Image (Filkri 04)
An illustration of a FILKRI filgrastim-laha injection syringe showing labeled parts such as the medicine window with markings, label with expiration date, and a gray needle cap. The syringe is designed for intravenous or subcutaneous use.*
Image (Filkri 04a)
An instructional diagram showing two prefilled syringes of FILKRI (filgrastim-laha) injection. The upper syringe is labeled as ready to use, and the lower syringe features an activated needle guard for safety. The image highlights syringe readiness and needle guard status.*
Image (Filkri 05)
Illustration showing components of an injection kit for FILKRI (filgrastim-laha). It includes a prefilled syringe with measurement markings, an alcohol wipe, an adhesive bandage, a cotton ball, and a disposal container.*
Image (Filkri 06)
An anatomical illustration showing recommended injection sites for FILKRI (filgrastim-laha) injection. The marked areas for injection include the upper arm, stomach area (abdomen), thigh, and upper outer area of the buttocks, indicating possible locations for intravenous or subcutaneous administration.*
Image (Filkri 08)
An instructional illustration showing two hands handling a syringe. One hand holds the syringe with the needle pointing upward, while the other hand removes a protective cap by pulling it off the needle. The image demonstrates how to prepare the syringe for injection.*
Image (Filkri 09)
Image (Filkri 10)
An instructional illustration showing two hands handling a syringe. One hand holds the syringe upright, while the other hand pinches a small area above the syringe, indicating preparation or administration technique. An arrow points to the syringe with sound wave lines suggesting an action or alert.*
Image (Filkri 11)
An instructional diagram showing how to set a partial dose using a syringe. Two hand-drawn illustrations depict a syringe held with fingers, with arrows indicating movement. Two circular insets highlight the syringe dosage scale, showing the initial plunger position at the 0.5 mL mark and the adjusted position after setting a partial dose between 0.3 and 0.4 mL.*
Image (Filkri 13)
A black-and-white line drawing illustration showing a hand placed flat on the inner side of a bent forearm. The image likely depicts the site for intravenous or subcutaneous injection, consistent with injection instructions for the drug FILKRI (filgrastim-laha).*
Image (Filkri 14)
An instructional illustration showing the technique for subcutaneous injection. It depicts a hand holding a syringe positioned at a 45-degree angle to the skin surface, with another hand stretching the skin taut. A small inset diagram contrasts the 45-degree injection angle with a 90-degree angle for reference.*
Image (Filkri 15)
Instructional illustration showing the proper technique for administering an injection subcutaneously using a syringe device. The image depicts a hand holding a prefilled syringe vertically above the injection site on the skin, with an arrow indicating downward movement to insert the needle.*
Image (Filkri 16)
An instructional line drawing showing a hand holding a prefilled syringe poised for subcutaneous injection into the abdomen, indicated by an upward arrow. The illustration demonstrates the correct technique for administering an injection beneath the skin. This is relevant to FILKRI (filgrastim-laha) injection, solution, used via intravenous or subcutaneous routes.*
Image (Filkri 17)
An instructional line drawing depicting a hand holding a syringe-like injection device positioned near a person's abdomen. An upward arrow indicates the motion of pulling or removing a cap or cover from the device before administration.*
Image (Filkri 18)
An instructional illustration showing a hand holding a pre-filled syringe and inserting it into a sharps disposal container. The image demonstrates safe disposal of a used injection device, likely for the FILKRI injection solution.*
Principal Display Panel (Filkri 32)
Label for FILKRI (filgrastim-laha) injection, 300 mcg/0.5 mL prefilled syringe, by Accord BioPharma Inc. The label includes dosage form as an injection solution for subcutaneous or intravenous use. It shows details about storage, manufacturer information, NDC 69448-008-63, and instructions indicating it is a single-dose prefilled syringe with no preservative.*
Principal Display Panel (Filkri 33)
FILKRI (filgrastim-laha) Injection 300 mcg/0.5 mL carton label for prefilled syringes. The label shows the product name, dosage strength, and injection form. It notes subcutaneous and intravenous use, manufacturer Accord BioPharma Inc., and includes storage instructions to keep refrigerated at 2°C to 8°C. The package contains ten single-dose prefilled syringes with no preservative.*
Principal Display Panel (Filkri 34)
FILKRI (filgrastim-laha) Injection 300 mcg/0.5 mL prefilled syringe label. For subcutaneous or intravenous use only, this single-dose sterile solution contains filgrastim-laha and excipients. Manufactured by Accord BioPharma Inc. Storage instructions and warnings are included on the label.*
Image (Filkri 35)
FILKRI (filgrastim-laha) injection 300 mcg/0.5 mL single-dose prefilled syringe label. It is for subcutaneous or intravenous use only. Label shows NDC 69448-008-63, manufacturer Accord BioPharma Inc., Raleigh, NC, and includes a barcode and lot/expiration space.*
Image (Filkri 36)
FILKRI (filgrastim-laha) Injection 480 mcg/0.8 mL carton label shows a human prescription drug for subcutaneous or intravenous use. The label includes NDC 69448-009-63, manufacturer Accord BioPharma Inc., and lists storage instructions, contents, and dosing guidance. The product is a sterile prefilled syringe solution without preservative.*
Image (Filkri 37)
FILKRI 480 mcg/0.8 mL Injection (filgrastim-laha) packaging label for prefilled syringes by Accord BioPharma Inc. The label shows the product is a sterile solution for subcutaneous or intravenous use, contains 480 mcg filgrastim-laha per 0.8 mL, and includes ten single-dose prefilled syringes. Manufactured by Accord BioPharma in the USA and Intas Pharmaceuticals in India.*
Image (Filkri 38)
FILKRI (filgrastim-laha) Injection 480 mcg/0.8 mL prefilled syringe label. The label states the product is for subcutaneous or intravenous use. It includes information on the active ingredient, storage conditions (refrigeration at 2°C to 8°C), ingredients, and manufacturer Accord BioPharma Inc., Raleigh, NC. The label also highlights the presence of dry natural rubber and that the solution contains no preservatives.*
Image (Filkri 39)
Label for FILKRI (filgrastim-laha) Injection, 480 mcg/0.8 mL. The label indicates this is a single-dose prefilled syringe for subcutaneous or intravenous use. Labeler information states Accord BioPharma Inc., Raleigh, NC. The label includes the NDC code 69448-009-63 and instructions to discard unused portions.*
Image (Filkri 40)
An instructional illustration showing a hand dropping cylindrical items into a cup or container, indicating a step in handling or preparation, possibly related to medication or device use.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
